Clinical Trial Update: Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial [Phase 2]

View source ↗

Summary

Phase 2 BALANCE trial evaluating radiation therapy with or without apalutamide for recurrent or advanced prostate cancer; currently listed as active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ERLEADA (apalutamide)

Snippet

Sponsor: NRG Oncology | Conditions: Recurrent Prostate Carcinoma, Stage III Prostate Adenocarcinoma AJCC v7 | Phase 2 | Status: ACTIVE_NOT_RECRUITING